Back to Search Start Over

Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants.

Authors :
Gök V
Leblebisatan G
Gürlek Gökçebay D
Güler S
Doğan ME
Tuğ Bozdoğan S
Koca Yozgat A
Özcan A
Pekpak Şahinoğlu E
Tokgöz H
Çil M
Özemri Sağ Ş
Yilmaz E
Şaşmaz Hİ
Evim MS
Akbayram S
Karadoğan M
Mutlu FT
Boğa İ
Yeter Doğan B
Yarali N
Çalişkan Ü
Bişgin A
Temel ŞG
Proven M
Gibson K
Demir BŞ
Saraçoğlu H
Eken A
Karakükçü Ç
Karakükçü M
Güneş AM
Özbek NY
Kilinç Y
Patiroğlu T
Özdemir MA
Roy NBA
Ünal E
Source :
British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 236-242. Date of Electronic Publication: 2024 May 29.
Publication Year :
2024

Abstract

Pyruvate kinase (PK) is a key enzyme of anaerobic glycolysis. The genetic heterogeneity of PK deficiency (PKD) is high, and over 400 unique variants have been identified. Twenty-nine patients who had been diagnosed as PKD genetically in seven distinct paediatric haematology departments were evaluated. Fifteen of 23 patients (65.2%) had low PK levels. The PK:hexokinase ratio had 100% sensitivity for PKD diagnosis, superior to PK enzyme assay. Two novel intronic variants (c.695-1G>A and c.694+43C>T) have been described. PKD should be suspected in patients with chronic non-spherocytic haemolytic anaemia, even if enzyme levels are falsely normal. Total PKLR gene sequencing is necessary for the characterization of patients with PKD and for genetic counselling.<br /> (© 2024 British Society for Haematology and John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1365-2141
Volume :
205
Issue :
1
Database :
MEDLINE
Journal :
British journal of haematology
Publication Type :
Academic Journal
Accession number :
38811201
Full Text :
https://doi.org/10.1111/bjh.19575